84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]赫軍,李冬冬,禹建春,等.綜合療法治療老年原發(fā)性骨質疏松癥[J].中醫(yī)正骨,2017,29(12):56-58.
點擊復制

綜合療法治療老年原發(fā)性骨質疏松癥()
分享到:

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第29卷
期數:
2017年12期
頁碼:
56-58
欄目:
臨床報道
出版日期:
2017-12-20

文章信息/Info

作者:
赫軍李冬冬禹建春方蘇亭孫捷
浙江省臺州市博愛醫(yī)院,浙江 臺州 318050
關鍵詞:
骨質疏松 綜合療法
摘要:
目的:觀察綜合療法治療老年原發(fā)性骨質疏松癥的臨床療效及安全性。方法:2015年6月至2017年8月,采用健康指導、口服西藥及中藥治療老年原發(fā)性骨質疏松癥患者30例。男2例,女28例。年齡73~97歲,中位數78.5歲。病程4個月至6年,中位數14.5個月。健康指導貫穿于整個治療過程。碳酸鈣D3片,每日1片,晚睡前口服; 阿侖膦酸鈉片,每周1片,晨起空腹口服,服后禁食30 min; 自擬中藥固本強骨飲,每日1劑,早晚各服用1次; 30 d為1個療程,連續(xù)治療3個療程。采用《中藥新藥臨床研究指導原則(試行)》中骨質疏松癥的癥狀分級量化表評定中醫(yī)證候積分,測定患者的骨密度、血清鈣和血清磷含量,采用視覺模擬量表(visual analogue scale,VAS)評定腰背部疼痛情況,采用《中藥新藥臨床研究指導原則(試行)》中骨質疏松癥的證候療效判定標準評價綜合療效。治療期間觀察不良反應發(fā)生情況。結果:治療3個療程后,30例患者的中醫(yī)證候積分、血清鈣含量、血清磷含量及腰背部疼痛VAS評分均較治療前下降[(12.09±4.89)分,(8.36±3.78)分,t=3.017,P=0.002;(26.07±1.56)mg·dL-1,(14.60±2.35)mg·dL-1,t=3.012,P=0.002;(25.06±1.01)mg·dL-1,(13.31±1.02)mg·dL-1,t=3.002,P=0.002;(8.86±1.14)分,(3.81±1.02)分,t=2.032,P=0.002],骨密度較治療前增高[(0.69±0.15)g·cm-2,(0.81±0.15)g·cm-2,t=2.013,P=0.001]; 按照上述證候療效標準評價綜合療效,臨床痊愈1例、顯效10例、有效16例、無效3例。治療期間出現便溏2例、食欲下降2例、惡心及干嘔1例,均未進行特殊處理,自然緩解。結論:綜合療法治療老年原發(fā)性骨質疏松癥,可以調節(jié)血清鈣和血清磷含量,提高骨密度,減輕腰背部疼痛,具有綜合療效好、安全性高的優(yōu)點。

參考文獻/References:

[1] MAJUMDAR SR,LESLIEW WD,LIX LM,et al.Longer duration of diabetes strongly impacts fracture risk assessment:the Manitoba BMD cohort[J].J Clin Endocrinol Metab,2016,101(11):4489-4496.
[2] BECKERLEG W,OOMMEN RA.Osteoporosis management in residential care:How internal and family medicine resident physicians translate evidence into practice[J].Can Fam Physician,2017,63(5):411-412.
[3] LIU M,ZHANGY,CHENG X,et al.The effect of age on the changes in bone mineral density and osteoporosis detection rates in Han Chinese men over the age of 50[J].Aging Male,2014,17(3):166-173.
[4] SALE JE,BEATON D,BOGOCH E.Secondary prevention after an osteoporosis-related fracture:an overview[J].Clin Geriatr Med,2014,30(2):317-332.
[5] 張智海,劉忠厚,李娜,等.中國人骨質疏松癥診斷標準專家共識(第三稿·2014版)[J].中國骨質疏松雜志,2014,20(9):1007-1010.
[6] 國家中醫(yī)藥管理局.中醫(yī)內科病證診斷療效標準(十六)[J].湖北中醫(yī)雜志,2003,25(10):封三.
[7] 鄭莜萸.中藥新藥臨床研究指導原則(試行)[M].北京:中國醫(yī)藥科技出版社,2002:357-358.
[8] 張智海,劉忠厚,石少輝,等.中國大陸地區(qū)以-2.5SD為診斷的骨質疏松癥發(fā)病率文獻回顧性研究[J].中國骨質疏松雜志,2015,21(1):1-7.
[9] 陳林,程軍,李波,等.渝東北地區(qū)老年人骨質疏松流行病學調查[J].中國骨質疏松雜志,2016,22(8):1050-1052.
[10] ABDI F,MOBEDI H,BAYAT F,et al.The effects of transdermal estrogen delivery on bone mineral density in postmenopausal women:a meta-analysis[J].Iran J Pharm Res,2017,16(1):380-389.
[11] 石隕.膏方調治骨質疏松癥探析[J].中醫(yī)正骨,2016,28(6):53-55.
[12] 邢潤麟,王培民,張農山,等.中醫(yī)“肝腎同源”理論異病同治膝骨關節(jié)炎和絕經后骨質疏松癥的實驗理論基礎研究[J].中醫(yī)正骨,2017,29(1):1-10.
[13] 黃易之,盧新剛,瞿佶,等.中醫(yī)藥治療老年骨質疏松癥研究進展[J].老年醫(yī)學與保健,2015,21(2):119-120.
[14] 張震宇,侯勇,王冠,等.運動對預防老年骨質疏松性骨折的作用[J].中國老年學雜志,2013,33(8):1977-1978.
[15] 孫玉敏,李媛.中藥防治骨質疏松的研究進展[J].醫(yī)學綜述,2016,22(17):3448-3450.
[16] 王昭洪,曾濤.補腎中藥治療骨質疏松的實驗研究進展[J].環(huán)球中醫(yī)藥,2011,4(3):235-238.
[17] 王翔,石印玉.補腎中藥防治骨質疏松癥基礎研究進展[J].中醫(yī)正骨,2003,15(3):52-54.
[18] 嚴紅梅,張振海,孫娥,等.中藥治療骨質疏松癥的研究進展[J].中草藥,2014,45(8):1174-1178.
[19] 史曉林,王健,王博,等.虛瘀兼顧--治療原發(fā)性骨質疏松癥的基本原則[J].中醫(yī)正骨,2017,29(3):14-16.
[20] 王潔,王蕭楓.淫羊藿總黃酮的抗骨質疏松作用及其對調控成骨細胞分化及骨形成關鍵信號通路的影響[J].中醫(yī)正骨,2017,29(1):45-48.
[21] 黃宏興,陳彥東.中西醫(yī)結合防治骨質疏松癥的研究思路與方法[J].中醫(yī)正骨,2008,20(3):74-75.

相似文獻/References:

[1]李林軍.應用膨脹式椎弓根螺釘內固定治療合并骨質疏松的 胸腰椎退行性疾病[J].中醫(yī)正骨,2015,27(08):49.
[2]韓艷,溫利平,劉娜,等.補腎活血方對去卵巢大鼠骨代謝及骨密度的影響[J].中醫(yī)正骨,2015,27(12):7.
 HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(補腎活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(12):7.
[3]李學朋,朱立國.骨疏康膠囊對去卵巢大鼠骨小梁的影響[J].中醫(yī)正骨,2015,27(12):12.
 LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康膠囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(12):12.
[4]陳冠軍,陳揚,莊汝杰.可灌注骨水泥椎弓根螺釘系統(tǒng) 在老年腰椎疾患手術中的應用[J].中醫(yī)正骨,2015,27(02):40.
[5]王丹輝,賁越,韓梅.林蛙油治療絕經后骨質疏松癥的臨床研究[J].中醫(yī)正骨,2014,26(01):27.
 Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(12):27.
[6]黃建華,黃建武,李慧輝,等.加味左歸丸對絕經后骨質疏松癥肝腎不足證 患者骨密度的影響[J].中醫(yī)正骨,2013,25(11):19.
 Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(12):19.
[7]項旻,楊虹,林愛菊,等.絕經后2型糖尿病患者骨質疏松與血微量元素的關系研究[J].中醫(yī)正骨,2013,25(12):20.
 Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(12):20.
[8]史曉林,李春雯,張志強.弱陽離子磁珠分離技術和基質輔助激光解吸電離飛行時間質譜技術在原發(fā)性Ⅰ型骨質疏松癥血清標志蛋白篩選中的應用[J].中醫(yī)正骨,2014,26(03):5.
 Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(12):5.
[9]李明,徐明雄,馮左基,等.自擬壯骨方治療絕經后骨質疏松癥的療效及作用機制研究[J].中醫(yī)正骨,2014,26(09):21.
 Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(12):21.
[10]陳俊杰,李晴晴,夏瑢.脂代謝及血清內脂素水平與絕經后骨質疏松癥的 相關性研究[J].中醫(yī)正骨,2012,24(04):16.
 CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(12):16.

更新日期/Last Update: 2018-05-02